Vanda Pharmaceuticals (NASDAQ:VNDA) Cut to Hold at StockNews.com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Reminds Vanda’s Board of Their Fiduciary Duties Given the Mishandling of Future Pak’s Offer to Acquire Vanda’s Underperforming and Undervalued Shares at an ~80-90% Premium Expresses Serious.
WASHINGTON, April 22, 2024 /PRNewswire/ Vanda Pharmaceuticals Inc. today announced that the Supreme Court denied Vanda s petition for a writ of certiorari in its HETLIOZ® Abbreviated New Drug.
The U.S. Supreme Court has reportedly chosen not to review Vanda Pharmaceuticals Inc’s VNDA attempt to revive patents for its sleep-disorder medication…